APO Research
Talk to an analyst

APO RESEARCH · REPORT

Somatostatin

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

Selected research

Industry Growth & Trends

Global Somatostatin Industry Growth and Trends Forecast to 2032

22 December 2025118 pages

Choose your research edition.

Industry ResearchSomatostatin Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Somatostatin Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Somatostatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Somatostatin Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Somatostatin Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.

China is the largest market, followed by Europe and India.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Somatostatin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Somatostatin market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Somatostatin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Somatostatin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Somatostatin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Somatostatin Market by Company

Merck (Schweiz) AG

SANOFI-AVENTIS FRANCE

Lyomark Pharma GmbH

ALFA WASSERMANN S.p.A.

Polypeptide Laboratories, Inc

SAMARTH

UBPL

HYBIO

TianTaiShan

Yangtze River

Siyao

Shuangcheng

Hainan Zhonghe

SL PHARM

Wuhan Hualong

Qingdao Guoda

Chengdu Shengnuo

Longjin

Somatostatin Segment by Type

0.25mg/pcs

0.75mg/pcs

3mg/pcs

Somatostatin Segment by Application

Hormonal Disorder

Oncology

Metabolic Disorder

Others

Somatostatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Somatostatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Somatostatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Somatostatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Somatostatin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Somatostatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.25mg/pcs Table 2. Major Company of 0.75mg/pcs Table 3. Major Company of 3mg/pcs Table 4. Global Somatostatin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Somatostatin Sales by Type (2021-2026) & (K Pcs) Table 6. Global Somatostatin Sales Market Share in Volume by Type (2021-2026) Table 7. Global Somatostatin Sales by Type (2021-2026) & (US$ Million) Table 8. Global Somatostatin Sales Market Share in Value by Type (2021-2026) Table 9. Global Somatostatin Price by Type (2021-2026) & (USD/Pcs) Table 10. Global Somatostatin Sales by Type (2027-2032) & (K Pcs) Table 11. Global Somatostatin Sales Market Share in Volume by Type (2027-2032) Table 12. Global Somatostatin Sales by Type (2027-2032) & (US$ Million) Table 13. Global Somatostatin Sales Market Share in Value by Type (2027-2032) Table 14. Global Somatostatin Price by Type (2027-2032) & (USD/Pcs) Table 15. North America Somatostatin Sales by Type (2021-2026) & (K Pcs) Table 16. North America Somatostatin Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Somatostatin Sales by Type (2021-2026) & (K Pcs) Table 18. Europe Somatostatin Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Somatostatin Sales by Type (2021-2026) & (K Pcs) Table 20. Asia-Pacific Somatostatin Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Somatostatin Sales by Type (2021-2026) & (K Pcs) Table 22. Latin America Somatostatin Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Somatostatin Sales by Type (2021-2026) & (K Pcs) Table 24. Middle East and Africa Somatostatin Sales by Type (2021-2026) & (US$ Million) Table 25. Somatostatin Industry Trends Table 26. Somatostatin Industry Drivers Table 27. Somatostatin Industry Opportunities and Challenges Table 28. Somatostatin Industry Restraints Table 29. Global Somatostatin Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Somatostatin Revenue Market Share by Company (2021-2026) Table 31. Global Somatostatin Sales by Company (2021-2026) & (K Pcs) Table 32. Global Somatostatin Sales Share by Company (2021-2026) Table 33. Global Somatostatin Market Price by Company (2021-2026) & (USD/Pcs) Table 34. Global Somatostatin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Somatostatin Major Company Production Sites and Headquarters Table 36. Global Somatostatin Company, Product Type & Application Table 37. Global Somatostatin Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Somatostatin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Somatostatin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Somatostatin Sales by Region (2021-2026) & (K Pcs) Table 42. Global Somatostatin Sales Market Share in Volume by Region (2021-2026) Table 43. Global Somatostatin Sales by Region (2021-2026) & (US$ Million) Table 44. Global Somatostatin Sales Market Share in Value by Region (2021-2026) Table 45. Global Somatostatin Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 46. Global Somatostatin Sales by Region (2027-2032) & (K Pcs) Table 47. Global Somatostatin Sales Market Share in Volume by Region (2027-2032) Table 48. Global Somatostatin Sales by Region (2027-2032) & (US$ Million) Table 49. Global Somatostatin Sales Market Share in Value by Region (2027-2032) Table 50. Global Somatostatin Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2027-2032) Table 51. Global Somatostatin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Somatostatin Sales by Application (2021-2026) & (K Pcs) Table 53. Global Somatostatin Sales Market Share in Volume by Application (2021-2026) Table 54. Global Somatostatin Sales by Application (2021-2026) & (US$ Million) Table 55. Global Somatostatin Sales Market Share in Value by Application (2021-2026) Table 56. Global Somatostatin Price by Application (2021-2026) & (USD/Pcs) Table 57. Global Somatostatin Sales by Application (2027-2032) & (K Pcs) Table 58. Global Somatostatin Sales Market Share in Volume by Application (2027-2032) Table 59. Global Somatostatin Sales by Application (2027-2032) & (US$ Million) Table 60. Global Somatostatin Sales Market Share in Value by Application (2027-2032) Table 61. Global Somatostatin Price by Application (2027-2032) & (USD/Pcs) Table 62. North America Somatostatin Sales by Application (2021-2026) & (K Pcs) Table 63. North America Somatostatin Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Somatostatin Sales by Application (2021-2026) & (K Pcs) Table 65. Europe Somatostatin Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Somatostatin Sales by Application (2021-2026) & (K Pcs) Table 67. Asia-Pacific Somatostatin Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Somatostatin Sales by Application (2021-2026) & (K Pcs) Table 69. Latin America Somatostatin Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Somatostatin Sales by Application (2021-2026) & (K Pcs) Table 71. Middle East and Africa Somatostatin Sales by Application (2021-2026) & (US$ Million) Table 72. Merck (Schweiz) AG Company Information Table 73. Merck (Schweiz) AG Business Overview Table 74. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 75. Merck (Schweiz) AG Somatostatin Product Portfolio Table 76. Merck (Schweiz) AG Recent Development Table 77. SANOFI-AVENTIS FRANCE Company Information Table 78. SANOFI-AVENTIS FRANCE Business Overview Table 79. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 80. SANOFI-AVENTIS FRANCE Somatostatin Product Portfolio Table 81. SANOFI-AVENTIS FRANCE Recent Development Table 82. Lyomark Pharma GmbH Company Information Table 83. Lyomark Pharma GmbH Business Overview Table 84. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 85. Lyomark Pharma GmbH Somatostatin Product Portfolio Table 86. Lyomark Pharma GmbH Recent Development Table 87. ALFA WASSERMANN S.p.A. Company Information Table 88. ALFA WASSERMANN S.p.A. Business Overview Table 89. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 90. ALFA WASSERMANN S.p.A. Somatostatin Product Portfolio Table 91. ALFA WASSERMANN S.p.A. Recent Development Table 92. Polypeptide Laboratories, Inc Company Information Table 93. Polypeptide Laboratories, Inc Business Overview Table 94. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 95. Polypeptide Laboratories, Inc Somatostatin Product Portfolio Table 96. Polypeptide Laboratories, Inc Recent Development Table 97. SAMARTH Company Information Table 98. SAMARTH Business Overview Table 99. SAMARTH Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 100. SAMARTH Somatostatin Product Portfolio Table 101. SAMARTH Recent Development Table 102. UBPL Company Information Table 103. UBPL Business Overview Table 104. UBPL Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 105. UBPL Somatostatin Product Portfolio Table 106. UBPL Recent Development Table 107. HYBIO Company Information Table 108. HYBIO Business Overview Table 109. HYBIO Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 110. HYBIO Somatostatin Product Portfolio Table 111. HYBIO Recent Development Table 112. TianTaiShan Company Information Table 113. TianTaiShan Business Overview Table 114. TianTaiShan Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 115. TianTaiShan Somatostatin Product Portfolio Table 116. TianTaiShan Recent Development Table 117. Yangtze River Company Information Table 118. Yangtze River Business Overview Table 119. Yangtze River Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 120. Yangtze River Somatostatin Product Portfolio Table 121. Yangtze River Recent Development Table 122. Siyao Company Information Table 123. Siyao Business Overview Table 124. Siyao Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 125. Siyao Somatostatin Product Portfolio Table 126. Siyao Recent Development Table 127. Shuangcheng Company Information Table 128. Shuangcheng Business Overview Table 129. Shuangcheng Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 130. Shuangcheng Somatostatin Product Portfolio Table 131. Shuangcheng Recent Development Table 132. Hainan Zhonghe Company Information Table 133. Hainan Zhonghe Business Overview Table 134. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 135. Hainan Zhonghe Somatostatin Product Portfolio Table 136. Hainan Zhonghe Recent Development Table 137. SL PHARM Company Information Table 138. SL PHARM Business Overview Table 139. SL PHARM Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 140. SL PHARM Somatostatin Product Portfolio Table 141. SL PHARM Recent Development Table 142. Wuhan Hualong Company Information Table 143. Wuhan Hualong Business Overview Table 144. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 145. Wuhan Hualong Somatostatin Product Portfolio Table 146. Wuhan Hualong Recent Development Table 147. Qingdao Guoda Company Information Table 148. Qingdao Guoda Business Overview Table 149. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 150. Qingdao Guoda Somatostatin Product Portfolio Table 151. Qingdao Guoda Recent Development Table 152. Chengdu Shengnuo Company Information Table 153. Chengdu Shengnuo Business Overview Table 154. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 155. Chengdu Shengnuo Somatostatin Product Portfolio Table 156. Chengdu Shengnuo Recent Development Table 157. Longjin Company Information Table 158. Longjin Business Overview Table 159. Longjin Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 160. Longjin Somatostatin Product Portfolio Table 161. Longjin Recent Development Table 162. North America Somatostatin Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 163. North America Somatostatin Sales by Country (2021-2026) & (K Pcs) Table 164. North America Somatostatin Sales Market Share by Country (2021-2026) Table 165. North America Somatostatin Sales Forecast by Country (2027-2032) & (K Pcs) Table 166. North America Somatostatin Sales Market Share Forecast by Country (2027-2032) Table 167. North America Somatostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. North America Somatostatin Market Size by Country (2021-2026) & (US$ Million) Table 169. North America Somatostatin Market Share by Country (2021-2026) Table 170. North America Somatostatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. North America Somatostatin Market Share Forecast by Country (2027-2032) Table 172. Europe Somatostatin Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 173. Europe Somatostatin Sales by Country (2021-2026) & (K Pcs) Table 174. Europe Somatostatin Sales Market Share by Country (2021-2026) Table 175. Europe Somatostatin Sales Forecast by Country (2027-2032) & (K Pcs) Table 176. Europe Somatostatin Sales Market Share Forecast by Country (2027-2032) Table 177. Europe Somatostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Europe Somatostatin Market Size by Country (2021-2026) & (US$ Million) Table 179. Europe Somatostatin Market Share by Country (2021-2026) Table 180. Europe Somatostatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Europe Somatostatin Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Somatostatin Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Somatostatin Sales by Country (2021-2026) & (K Pcs) Table 184. Asia-Pacific Somatostatin Sales Market Share by Country (2021-2026) Table 185. Asia-Pacific Somatostatin Sales Forecast by Country (2027-2032) & (K Pcs) Table 186. Asia-Pacific Somatostatin Sales Market Share Forecast by Country (2027-2032) Table 187. Asia-Pacific Somatostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Asia-Pacific Somatostatin Market Size by Country (2021-2026) & (US$ Million) Table 189. Asia-Pacific Somatostatin Market Share by Country (2021-2026) Table 190. Asia-Pacific Somatostatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Asia-Pacific Somatostatin Market Share Forecast by Country (2027-2032) Table 192. Latin America Somatostatin Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 193. Latin America Somatostatin Sales by Country (2021-2026) & (K Pcs) Table 194. Latin America Somatostatin Sales Market Share by Country (2021-2026) Table 195. Latin America Somatostatin Sales Forecast by Country (2027-2032) & (K Pcs) Table 196. Latin America Somatostatin Sales Market Share Forecast by Country (2027-2032) Table 197. Latin America Somatostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Latin America Somatostatin Market Size by Country (2021-2026) & (US$ Million) Table 199. Latin America Somatostatin Market Share by Country (2021-2026) Table 200. Latin America Somatostatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Latin America Somatostatin Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Somatostatin Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Somatostatin Sales by Country (2021-2026) & (K Pcs) Table 204. Middle East and Africa Somatostatin Sales Market Share by Country (2021-2026) Table 205. Middle East and Africa Somatostatin Sales Forecast by Country (2027-2032) & (K Pcs) Table 206. Middle East and Africa Somatostatin Sales Market Share Forecast by Country (2027-2032) Table 207. Middle East and Africa Somatostatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Middle East and Africa Somatostatin Market Size by Country (2021-2026) & (US$ Million) Table 209. Middle East and Africa Somatostatin Market Share by Country (2021-2026) Table 210. Middle East and Africa Somatostatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Middle East and Africa Somatostatin Market Share Forecast by Country (2027-2032) Table 212. Key Raw Materials Table 213. Raw Materials Key Suppliers Table 214. Somatostatin Distributors List Table 215. Somatostatin Customers List Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. Somatostatin Image Figure 2. Global Somatostatin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Somatostatin Market Size (2021-2032) & (US$ Million) Figure 4. Global Somatostatin Sales (2021-2032) & (K Pcs) Figure 5. 0.25mg/pcs Image Figure 6. Global 0.25mg/pcs Sales YoY Growth (2021-2032) & (K Pcs) Figure 7. 0.75mg/pcs Image Figure 8. Global 0.75mg/pcs Sales YoY Growth (2021-2032) & (K Pcs) Figure 9. 3mg/pcs Image Figure 10. Global 3mg/pcs Sales YoY Growth (2021-2032) & (K Pcs) Figure 11. Global Somatostatin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Somatostatin Market Share by Type 2025 VS 2032 Figure 13. North America Somatostatin Sales Market Share in Volume by Type in 2025 Figure 14. North America Somatostatin Sales Market Share in Value by Type in 2025 Figure 15. Europe Somatostatin Sales Market Share in Volume by Type in 2025 Figure 16. Europe Somatostatin Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Somatostatin Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Somatostatin Sales Market Share in Value by Type in 2025 Figure 19. Latin America Somatostatin Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Somatostatin Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Somatostatin Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Somatostatin Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Somatostatin Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hormonal Disorder Image Figure 26. Global Hormonal Disorder Sales YoY Growth (2021-2032) & (K Pcs) Figure 27. Oncology Image Figure 28. Global Oncology Sales YoY Growth (2021-2032) & (K Pcs) Figure 29. Metabolic Disorder Image Figure 30. Global Metabolic Disorder Sales YoY Growth (2021-2032) & (K Pcs) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Pcs) Figure 33. Global Somatostatin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Somatostatin Market Share by Application 2025 VS 2032 Figure 35. North America Somatostatin Sales Market Share in Volume by Application in 2025 Figure 36. North America Somatostatin Sales Market Share in Value by Application in 2025 Figure 37. Europe Somatostatin Sales Market Share in Volume by Application in 2025 Figure 38. Europe Somatostatin Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Somatostatin Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Somatostatin Sales Market Share in Value by Application in 2025 Figure 41. Latin America Somatostatin Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Somatostatin Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Somatostatin Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Somatostatin Sales Market Share in Value by Application in 2025 Figure 45. North America Somatostatin Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 46. North America Somatostatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Somatostatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Somatostatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Somatostatin Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 50. Europe Somatostatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Somatostatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Somatostatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Somatostatin Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 54. Asia-Pacific Somatostatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Somatostatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Somatostatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Somatostatin Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 58. Latin America Somatostatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Somatostatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Somatostatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Somatostatin Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 62. Middle East and Africa Somatostatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Somatostatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Somatostatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Somatostatin Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Somatostatin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25mg/pcs
  • 0.75mg/pcs
  • 3mg/pcs
Applications
  • Hormonal Disorder
  • Oncology
  • Metabolic Disorder
  • Others
Companies covered
  • Merck (Schweiz) AG
  • SANOFI-AVENTIS FRANCE
  • Lyomark Pharma GmbH
  • ALFA WASSERMANN S.p.A.
  • Polypeptide Laboratories, Inc
  • SAMARTH
  • UBPL
  • HYBIO
  • TianTaiShan
  • Yangtze River
  • Siyao
  • Shuangcheng
  • Hainan Zhonghe
  • SL PHARM
  • Wuhan Hualong
  • Qingdao Guoda
  • Chengdu Shengnuo
  • Longjin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Somatostatin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Somatostatin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Somatostatin Market by Type
  6. 1.3.1 0.25mg/pcs
  7. 1.3.2 0.75mg/pcs
  8. 1.3.3 3mg/pcs
  9. 1.4 Global Somatostatin Market Size by Type
  10. 1.4.1 Global Somatostatin Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Somatostatin Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Somatostatin Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Somatostatin Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Somatostatin Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Somatostatin Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Somatostatin Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Somatostatin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Somatostatin Industry Trends
  2. 2.2 Somatostatin Industry Drivers
  3. 2.3 Somatostatin Industry Opportunities and Challenges
  4. 2.4 Somatostatin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Somatostatin Revenue (2021-2026)
  2. 3.2 Global Top Players by Somatostatin Sales (2021-2026)
  3. 3.3 Global Top Players by Somatostatin Price (2021-2026)
  4. 3.4 Global Somatostatin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Somatostatin Major Company Production Sites & Headquarters
  6. 3.6 Global Somatostatin Company, Product Type & Application
  7. 3.7 Global Somatostatin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Somatostatin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Somatostatin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Somatostatin Tier 1, Tier 2, and Tier 3
4 Somatostatin Regional Status and Outlook
  1. 4.1 Global Somatostatin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Somatostatin Historic Market Size by Region
  3. 4.2.1 Global Somatostatin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Somatostatin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Somatostatin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Somatostatin Forecasted Market Size by Region
  7. 4.3.1 Global Somatostatin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Somatostatin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Somatostatin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Somatostatin by Application
  1. 5.1 Somatostatin Market by Application
  2. 5.1.1 Hormonal Disorder
  3. 5.1.2 Oncology
  4. 5.1.3 Metabolic Disorder
  5. 5.1.4 Others
  6. 5.2 Global Somatostatin Market Size by Application
  7. 5.2.1 Global Somatostatin Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Somatostatin Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Somatostatin Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Somatostatin Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Somatostatin Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Somatostatin Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Somatostatin Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Somatostatin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck (Schweiz) AG
  2. 6.1.1 Merck (Schweiz) AG Company Information
  3. 6.1.2 Merck (Schweiz) AG Business Overview
  4. 6.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck (Schweiz) AG Somatostatin Product Portfolio
  6. 6.1.5 Merck (Schweiz) AG Recent Developments
  7. 6.2 SANOFI-AVENTIS FRANCE
  8. 6.2.1 SANOFI-AVENTIS FRANCE Company Information
  9. 6.2.2 SANOFI-AVENTIS FRANCE Business Overview
  10. 6.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SANOFI-AVENTIS FRANCE Somatostatin Product Portfolio
  12. 6.2.5 SANOFI-AVENTIS FRANCE Recent Developments
  13. 6.3 Lyomark Pharma GmbH
  14. 6.3.1 Lyomark Pharma GmbH Company Information
  15. 6.3.2 Lyomark Pharma GmbH Business Overview
  16. 6.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lyomark Pharma GmbH Somatostatin Product Portfolio
  18. 6.3.5 Lyomark Pharma GmbH Recent Developments
  19. 6.4 ALFA WASSERMANN S.p.A.
  20. 6.4.1 ALFA WASSERMANN S.p.A. Company Information
  21. 6.4.2 ALFA WASSERMANN S.p.A. Business Overview
  22. 6.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ALFA WASSERMANN S.p.A. Somatostatin Product Portfolio
  24. 6.4.5 ALFA WASSERMANN S.p.A. Recent Developments
  25. 6.5 Polypeptide Laboratories, Inc
  26. 6.5.1 Polypeptide Laboratories, Inc Company Information
  27. 6.5.2 Polypeptide Laboratories, Inc Business Overview
  28. 6.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Polypeptide Laboratories, Inc Somatostatin Product Portfolio
  30. 6.5.5 Polypeptide Laboratories, Inc Recent Developments
  31. 6.6 SAMARTH
  32. 6.6.1 SAMARTH Company Information
  33. 6.6.2 SAMARTH Business Overview
  34. 6.6.3 SAMARTH Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SAMARTH Somatostatin Product Portfolio
  36. 6.6.5 SAMARTH Recent Developments
  37. 6.7 UBPL
  38. 6.7.1 UBPL Company Information
  39. 6.7.2 UBPL Business Overview
  40. 6.7.3 UBPL Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 UBPL Somatostatin Product Portfolio
  42. 6.7.5 UBPL Recent Developments
  43. 6.8 HYBIO
  44. 6.8.1 HYBIO Company Information
  45. 6.8.2 HYBIO Business Overview
  46. 6.8.3 HYBIO Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 HYBIO Somatostatin Product Portfolio
  48. 6.8.5 HYBIO Recent Developments
  49. 6.9 TianTaiShan
  50. 6.9.1 TianTaiShan Company Information
  51. 6.9.2 TianTaiShan Business Overview
  52. 6.9.3 TianTaiShan Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 TianTaiShan Somatostatin Product Portfolio
  54. 6.9.5 TianTaiShan Recent Developments
  55. 6.10 Yangtze River
  56. 6.10.1 Yangtze River Company Information
  57. 6.10.2 Yangtze River Business Overview
  58. 6.10.3 Yangtze River Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Yangtze River Somatostatin Product Portfolio
  60. 6.10.5 Yangtze River Recent Developments
  61. 6.11 Siyao
  62. 6.11.1 Siyao Company Information
  63. 6.11.2 Siyao Business Overview
  64. 6.11.3 Siyao Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Siyao Somatostatin Product Portfolio
  66. 6.11.5 Siyao Recent Developments
  67. 6.12 Shuangcheng
  68. 6.12.1 Shuangcheng Company Information
  69. 6.12.2 Shuangcheng Business Overview
  70. 6.12.3 Shuangcheng Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shuangcheng Somatostatin Product Portfolio
  72. 6.12.5 Shuangcheng Recent Developments
  73. 6.13 Hainan Zhonghe
  74. 6.13.1 Hainan Zhonghe Company Information
  75. 6.13.2 Hainan Zhonghe Business Overview
  76. 6.13.3 Hainan Zhonghe Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hainan Zhonghe Somatostatin Product Portfolio
  78. 6.13.5 Hainan Zhonghe Recent Developments
  79. 6.14 SL PHARM
  80. 6.14.1 SL PHARM Company Information
  81. 6.14.2 SL PHARM Business Overview
  82. 6.14.3 SL PHARM Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 SL PHARM Somatostatin Product Portfolio
  84. 6.14.5 SL PHARM Recent Developments
  85. 6.15 Wuhan Hualong
  86. 6.15.1 Wuhan Hualong Company Information
  87. 6.15.2 Wuhan Hualong Business Overview
  88. 6.15.3 Wuhan Hualong Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Wuhan Hualong Somatostatin Product Portfolio
  90. 6.15.5 Wuhan Hualong Recent Developments
  91. 6.16 Qingdao Guoda
  92. 6.16.1 Qingdao Guoda Company Information
  93. 6.16.2 Qingdao Guoda Business Overview
  94. 6.16.3 Qingdao Guoda Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Qingdao Guoda Somatostatin Product Portfolio
  96. 6.16.5 Qingdao Guoda Recent Developments
  97. 6.17 Chengdu Shengnuo
  98. 6.17.1 Chengdu Shengnuo Company Information
  99. 6.17.2 Chengdu Shengnuo Business Overview
  100. 6.17.3 Chengdu Shengnuo Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Chengdu Shengnuo Somatostatin Product Portfolio
  102. 6.17.5 Chengdu Shengnuo Recent Developments
  103. 6.18 Longjin
  104. 6.18.1 Longjin Company Information
  105. 6.18.2 Longjin Business Overview
  106. 6.18.3 Longjin Somatostatin Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Longjin Somatostatin Product Portfolio
  108. 6.18.5 Longjin Recent Developments
7 North America by Country
  1. 7.1 North America Somatostatin Sales by Country
  2. 7.1.1 North America Somatostatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Somatostatin Sales by Country (2021-2026)
  4. 7.1.3 North America Somatostatin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Somatostatin Market Size by Country
  6. 7.2.1 North America Somatostatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Somatostatin Market Size by Country (2021-2026)
  8. 7.2.3 North America Somatostatin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Somatostatin Sales by Country
  2. 8.1.1 Europe Somatostatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Somatostatin Sales by Country (2021-2026)
  4. 8.1.3 Europe Somatostatin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Somatostatin Market Size by Country
  6. 8.2.1 Europe Somatostatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Somatostatin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Somatostatin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Somatostatin Sales by Country
  2. 9.1.1 Asia-Pacific Somatostatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Somatostatin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Somatostatin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Somatostatin Market Size by Country
  6. 9.2.1 Asia-Pacific Somatostatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Somatostatin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Somatostatin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Somatostatin Sales by Country
  2. 10.1.1 South America Somatostatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Somatostatin Sales by Country (2021-2026)
  4. 10.1.3 South America Somatostatin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Somatostatin Market Size by Country
  6. 10.2.1 South America Somatostatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Somatostatin Market Size by Country (2021-2026)
  8. 10.2.3 South America Somatostatin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Somatostatin Sales by Country
  2. 11.1.1 Middle East and Africa Somatostatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Somatostatin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Somatostatin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Somatostatin Market Size by Country
  6. 11.2.1 Middle East and Africa Somatostatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Somatostatin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Somatostatin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Somatostatin Value Chain Analysis
  2. 12.1.1 Somatostatin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Somatostatin Production Mode & Process
  7. 12.2 Somatostatin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Somatostatin Distributors
  10. 12.2.3 Somatostatin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst